StockData
Zura Bio Ltd logo

Zura Bio Ltd (ZURA) stock

ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 5/30
$0.97−0.07 (-6.75%)

Close on Nov 18, 2026Market cap $92.96MP/E –Yield –

Zura Bio enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Zura Bio's enterprise value was -$68.68M on Nov 11, 2026, against $251.07M a year earlier. Over the last 4 years it ranged from -$99.97M to $378.36M, with a median of $101.92M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$68.68M-120.1%
2025Dec 31, 2025$342.10M–
2024Dec 31, 2024-$23.45M-123.7%
2023Dec 29, 2023$98.93M–

More Zura Bio figures

See a number that looks wrong?